S259-0494 Screening compound: {4-[(3,5-dimethyl-4-isoxazolyl)methyl]piperazino}(4,5,6,7-tetrahydro-1H-indazol-3-yl)methanone

S259-0494 Screening compound: {4-[(3,5-dimethyl-4-isoxazolyl)methyl]piperazino}(4,5,6,7-tetrahydro-1H-indazol-3-yl)methanone
S259-0494 Screening compound: {4-[(3,5-dimethyl-4-isoxazolyl)methyl]piperazino}(4,5,6,7-tetrahydro-1H-indazol-3-yl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound S259-0494
{4-[(3,5-dimethyl-4-isoxazolyl)methyl]piperazino}(4,5,6,7-tetrahydro-1H-indazol-3-yl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S259-0494

Molecular Formula

C18H25N5O2 (C18 H25 N5 O2)

Compound Name

{4-[(3,5-dimethyl-4-isoxazolyl)methyl]piperazino}(4,5,6,7-tetrahydro-1H-indazol-3-yl)methanone

IUPAC name

3-{4-[(35-dimethyl-12-oxazol-4-yl)methyl]piperazine-1-carbonyl}-4567-tetrahydro-1H-indazole

SMILES

Cc1noc(C)c1CN(CC1)CCN1C(c1n[nH]c2c1CCCC2)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

343.43

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.290

Distribution Coefficient, logD

0.917

Water Solubility, LogSw

-1.46

Polar Surface Area

67.419

Acid Dissociation Constant (pKa)

12.81

Base Dissociation Constant (pKb)

7.53

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

61.11

S259-0494 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

Soluble Diversity Library (15920 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with S259-0494 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S259-0494?
Check Price and Availability of S259-0494, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S259-0494 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S259-0494
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S259-0494
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S259-0494 available by request